The Global Urinalysis market is expected to reach $2.94 billion by 2026 growing at a CAGR of 8.6% during 2018 to 2026.
Based on Application, the Disease Screening segment has witnessed significant growth due to the fact that urine analysis has become a part of the general check-up in hospitals and clinics and to detect potential health disorders or diseases in people who do not have any symptoms of disease. The goal is early detection and lifestyle changes or surveillance, to reduce the risk of disease, or to detect it early enough to treat it most effectively.
Key Questions Answered in this Report:
- How this market evolved since the year 2016
- Market size estimations, forecasts and CAGR for all the segments presented in the scope
- Key Market Developments and financials of the key players
- Opportunity Analysis for the new entrants
- SWOT Analysis of the key players
- Fastest growing markets analyzed during the forecast period
Key Topics Covered:
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Urinalysis Market, By Test Type
5.2 Biochemical Urinalysis
5.3 Pregnancy & Fertility Tests
5.4 Sediment Urinalysis
6 Global Urinalysis Market, By Product
7 Global Urinalysis Market, By Test Setting
8 Global Urinalysis Market, By Application
8.2 Pregnancy & Fertility
8.3 Disease Screening
9 Global Urinalysis Market, By End User
9.2 Home Care Settings
9.3 Diagnostic Laboratories
9.5 Clinical Laboratories
9.6 Physician Practices
9.7 Research Lab
10 Global Urinalysis Market, By Geography
10.2 North America
10.4 Asia Pacific
10.5 South America
10.6 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 Cardinal Health, Inc.
12.2 Siemens Healthineers
12.3 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
12.4 Quidel Corporation
12.5 Arkray, Inc.
12.6 77 Elektronika Kft
12.7 Dirui Industrial Co., Ltd.
12.8 Alere, Inc. (A Part of Abbott Laboratories)
12.9 Roche Diagnostics
12.10 Sysmex Corporation
12.11 Bio-Rad Laboratories, Inc.
12.12 Acon Laboratories, Inc.
12.13 Urit Medical Electronic Group Co., Ltd.
12.14 Dirui Industrial Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/yqibsd